BioSpace News Archive

Intrexon Corporation announced it will release first quarter 2018 financial results after the market closes on Thursday, May 10th, 2018.

The first data from two Phase 3 studies of the investigational compound esketamine nasal spray in patients with treatment-resistant depression are among 17 abstracts from the Janssen Pharmaceutical Companies of Johnson & Johnson to be presented at the American Psychiatric Association (APA) Annual Meeting.

CRG announced the appointment of Todd Holmes as Principal in the firm’s Boulder office.

Benitec Biopharma Limited announced that it will host a conference call and webcast for investors and analysts on 15 May 2018.

Protagonist Therapeutics, Inc. announced that preclinical research findings on the Company’s selective dual mu/delta opioid receptor agonists have been accepted for oral presentation on Saturday, June 2, 2018 at the Digestive Diseases Week® (DDW) conference.

Baylor Scott & White Health and Select Medical today announced an expansion of their joint venture into the Austin area with the acquisition of a 36-bed inpatient rehabilitation hospital in Lakeway, Texas.

Dr. Sheffield’s Naturals brand will launch an engaging new app that blends authenticity with forward-thinking innovation.

Childhood food allergies are on the rise - according to FARE

Management to hold a conference call at 4:30 p.m. EDT

C4 Therapeutics (C4T) today announced that Andrew Phillips, Ph.D. has been appointed as President and Chief Executive Officer. Dr. Phillips has been leading C4T’s scientific efforts as Chief Scientific Officer since January 2016 and assumed corporate leadership responsibilities with his added appointment as President in September 2016